Haemonetics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Haemonetics generated cash of $181,751,000, which is less than the previous year. Cash used in financing activities reached the amount of $38,157,000 last year. Net change in cash is therefore -$105,666,000.
Cash Flow
| 2015 | 127.17M | -121.76M | -33.16M |
|---|---|---|---|
| 2016 | 121.86M | -104.76M | -62.62M |
| 2017 | 159.73M | -73.31M | -60.41M |
| 2018 | 220.35M | -63.04M | -120.64M |
| 2019 | 159.28M | -116.14M | -50.62M |
| 2020 | 158.21M | -57.17M | -131.20M |
| 2021 | 108.80M | -425.44M | 367.45M |
| 2022 | 172.26M | -86.34M | -15.74M |
| 2023 | 273.05M | -143.78M | -100.36M |
| 2024 | 181.75M | -322.38M | 38.15M |
HAE Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 284.46M | 259.49M | 192.30M | 137.31M | 169.35M | 180.16M | 139.56M | 115.12M | 160.66M | 192.46M |
Operating activities | ||||||||||
Net income | 117.55M | 115.40M | 43.37M | 79.46M | 76.52M | 55.01M | 45.57M | -26.26M | -55.62M | 16.89M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 97.21M | 93.30M | 97.74M | 84.28M | 110.28M | 109.41M | 89.24M | 89.73M | 90.03M | 86.05M |
Stock-based compensation expense | 28.33M | 25.58M | 24.35M | 25.51M | 20.45M | 17.18M | 13.02M | 9.15M | 6.94M | 14.09M |
| Deferred income tax benefit | 28.33M | 25.58M | 24.35M | 25.51M | 20.45M | 17.18M | 13.02M | 9.15M | 6.94M | 14.09M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -24.19M | -24.42M | -34.97M | 44.12M | 18.86M | -38.06M | 5.08M | 3.15M | -10.32M | 8.83M |
Inventories | -60.06M | 30.75M | 24.30M | -38.90M | -84.72M | -39.32M | 14.38M | -1.55M | 12.78M | -16.93M |
Accounts payable | 44.58M | 39.81M | 7.64M | -56.42M | -17.30M | 17.73M | 41.40M | 21.07M | -30.23M | 12.65M |
Cash generated by operating activities | 181.75M | 273.05M | 172.26M | 108.80M | 158.21M | 159.28M | 220.35M | 159.73M | 121.86M | 127.17M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -33.20M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -66.29M | -110.19M | -96.50M | -37.04M | -48.75M | -118.96M | -74.79M | -76.13M | -102.40M | -122.22M |
Acquisitions Net | -240.54M | -2M | 8.14M | -390.21M | -25.19M | 2.81M | 9M | 2.82M | -3M | 0 |
Cash generated by investing activities | -322.38M | -143.78M | -86.34M | -425.44M | -57.17M | -116.14M | -63.04M | -73.31M | -104.76M | -121.76M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | -3.22M | 12.01M | 0 | 40.34M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -75M | 0 | 0 | -175M | -160M | -100M | 0 | -60.98M | -39.03M |
Repayments of term debt | 37.75M | -9.62M | -17.5M | -81.87M | -13.12M | 95.92M | -60.98M | -93.41M | -21.34M | -8.73M |
Cash used in financing activities | 38.15M | -100.36M | -15.74M | 367.45M | -131.20M | -50.62M | -120.64M | -60.41M | -62.62M | -33.16M |
Net Change In Cash | -105.66M | 24.97M | 67.19M | 54.99M | -32.04M | -10.81M | 40.60M | 24.44M | -45.53M | -31.80M |
Cash at end of period | 178.8M | 284.46M | 259.49M | 192.30M | 137.31M | 169.35M | 180.16M | 139.56M | 115.12M | 160.66M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |